Amifostine protects primitive hematopoietic progenitors against chemotherapy cytotoxicity

Seminars in Oncology

Volumn 23, Issue 4 SUPPL. 8, 1996, Pages 58-63

  List, A F ^a   Heaton, R ^a   Glinsmann Gibson, B ^a   Capizzi, R L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; CISPLATIN; DIAZIQUONE; DOXORUBICIN; MITOXANTRONE; PACLITAXEL; THIOTEPA;

ANIMAL CELL; BLOOD TOXICITY; BURST FORMING UNIT E; CANCER CHEMOTHERAPY; CELL PROTECTION; CLINICAL TRIAL; COLONY FORMING UNIT GEMM; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG CYTOTOXICITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL;

AMIFOSTINE; ANTINEOPLASTIC AGENTS; BONE MARROW CELLS; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; MERCAPTOETHYLAMINES;

EID: 0029743651     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)